Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$652M
-
Value change
-
+$40.5M
-
Put/Call ratio
-
1.43
-
Number of buys
-
55
-
Number of sells
-
-39
-
Price
-
$24.01
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2017
139 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q3 2017.
Editas Medicine, Inc. - Common Stock (EDIT) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 82.8M outstanding shares and own 32.83% of the company stock.
Largest 10 shareholders include FMR LLC (4.53M shares), BlackRock Inc. (2.64M shares), VANGUARD GROUP INC (2.3M shares), STATE STREET CORP (1.85M shares), Polaris Venture Management Co. VI, L.L.C. (1.8M shares), Capital World Investors (1.77M shares), Viking Global Investors LP (1.71M shares), DEERFIELD MANAGEMENT CO (1.71M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.24M shares), and Ark Investment Management LLC (688K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.